Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Return on Assets (2016 - 2025)

Historic Return on Assets for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to 0.52%.

  • Viridian Therapeutics, Inc.\DE's Return on Assets fell 1400.0% to 0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year decrease of 1400.0%. This contributed to the annual value of 0.44% for FY2024, which is 800.0% up from last year.
  • According to the latest figures from Q3 2025, Viridian Therapeutics, Inc.\DE's Return on Assets is 0.52%, which was down 1400.0% from 0.55% recorded in Q2 2025.
  • Viridian Therapeutics, Inc.\DE's Return on Assets' 5-year high stood at 0.3% during Q4 2022, with a 5-year trough of 1.1% in Q2 2021.
  • Moreover, its 5-year median value for Return on Assets was 0.45% (2022), whereas its average is 0.53%.
  • Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Return on Assets surged by 9800bps in 2021 and then crashed by -2800bps in 2023.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Return on Assets (Quarter) stood at 0.37% in 2021, then rose by 21bps to 0.3% in 2022, then tumbled by -96bps to 0.58% in 2023, then soared by 39bps to 0.36% in 2024, then plummeted by -46bps to 0.52% in 2025.
  • Its last three reported values are 0.52% in Q3 2025, 0.55% for Q2 2025, and 0.44% during Q1 2025.